ARGENX SE

ARGX
Real-time Estimate Quote. Real-time Estimate  - 08/13 03:59:59 pm
200.6EUR +0.85%
Prev.198.9000
Open199.0000
High204.4000
Low198.5000
Volume77 798
Latest news
08/04
07/30
07/30
06/24
Chart ARGENX SE
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance214237232
Spread/Res.-6,1%-15%-13%
Spread/Supp.3,9%32%34%
Support193152150
Financials
Sales 2020 69,0 M 81,5 M 81,5 M
Net income 2020 -428 M -505 M -505 M
Net cash 2020 1 309 M 1 547 M 1 547 M
P/E ratio 2020 -23,8x
Yield 2020 -
Capitalization 9 459 M 11 189 M 11 176 M
EV / Sales 2020 118x
EV / Sales 2021 69,9x
Nbr of Employees 186
Free-Float 99,2%
Company
argenx SE is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group is focused on developing product candidates with the potential to be either first-in-class against novel...
Sector :
Bio Therapeutic Drugs
Calendar :
2020-10-22 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 228,99 €
Last Close Price 200,80 €
Spread / Highest target 44,4%
Spread / Average Target 14,0%
Spread / Lowest Target -3,39%